Search research articles
Contact Us
Filters
Showing results (421-430 of 840) with videos related to
Page
of 84
Sort By:
Cellular Microbiology
|
September 14, 2013
Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival
Laura J Macdonald, Joseph G Graham, Richard C Kurten, et al.
Infection and Immunity
|
February 24, 2016
Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii
Joseph G Graham, Caylin G Winchell, Richard C Kurten, et al.
The American Journal of Pathology
|
July 1, 1974
Bacteriocidal properties of a class of quinoid compounds related to sporulation in the mushroom, Agaricus bisporus
F S Vogel, S J McGarry, L A Kemper, et al.
Canadian Medical Association Journal
|
March 24, 2010
The Diabetic Journal
E E Claxton, G Graham, R D Lawrence, et al.
The Johns Hopkins Medical Journal
|
September 1, 1971
Lactose malabsorption and milk rejection in Negro children
D M Paige, T M Bayless, G D Ferry, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
May 1, 1989
The Duke University program for integrating ethics and human values into medical education
A C Puckett, D G Graham, L A Pounds, et al.
British Journal of Clinical Pharmacology
|
December 15, 2004
Stereoselective disposition of ibuprofen enantiomers in man. 1985
E J D Lee, K Williams, R Day, et al.
The Journal of Hand Surgery
|
May 29, 2018
Delayed, Atraumatic Index Metacarpal Fracture After Trapeziectomy and Suture-Button Suspensionplasty for Thumb Carpometacarpal Osteoarthritis: A Report of Three Cases
Jack G Graham, Michael Rivlin, Jack Abboudi, et al.
Journal of Neurochemistry
|
June 1, 1999
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin
M D Neely, K R Sidell, D G Graham, et al.
Pharmaceutical Research
|
October 6, 2001
Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan
I Nestorov, G Graham, S Duffull, et al.
Page
of 84
Search research articles
Search
Showing results (421-430 of 840) with videos related to
Sort By:
Page
of 84
Cellular Microbiology
|
September 14, 2013
Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival
Laura J Macdonald, Joseph G Graham, Richard C Kurten, et al.
Infection and Immunity
|
February 24, 2016
Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii
Joseph G Graham, Caylin G Winchell, Richard C Kurten, et al.
The American Journal of Pathology
|
July 1, 1974
Bacteriocidal properties of a class of quinoid compounds related to sporulation in the mushroom, Agaricus bisporus
F S Vogel, S J McGarry, L A Kemper, et al.
Canadian Medical Association Journal
|
March 24, 2010
The Diabetic Journal
E E Claxton, G Graham, R D Lawrence, et al.
The Johns Hopkins Medical Journal
|
September 1, 1971
Lactose malabsorption and milk rejection in Negro children
D M Paige, T M Bayless, G D Ferry, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
May 1, 1989
The Duke University program for integrating ethics and human values into medical education
A C Puckett, D G Graham, L A Pounds, et al.
British Journal of Clinical Pharmacology
|
December 15, 2004
Stereoselective disposition of ibuprofen enantiomers in man. 1985
E J D Lee, K Williams, R Day, et al.
The Journal of Hand Surgery
|
May 29, 2018
Delayed, Atraumatic Index Metacarpal Fracture After Trapeziectomy and Suture-Button Suspensionplasty for Thumb Carpometacarpal Osteoarthritis: A Report of Three Cases
Jack G Graham, Michael Rivlin, Jack Abboudi, et al.
Journal of Neurochemistry
|
June 1, 1999
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin
M D Neely, K R Sidell, D G Graham, et al.
Pharmaceutical Research
|
October 6, 2001
Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan
I Nestorov, G Graham, S Duffull, et al.
Page
of 84